𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Control of von Willebrand factor multimer size and implications for disease

✍ Scribed by John Pimanda; Philip Hogg


Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
197 KB
Volume
16
Category
Article
ISSN
0268-960X

No coin nor oath required. For personal study only.

✦ Synopsis


Plasma von Willebrand factor (vWF) is a multimeric protein that mediates adhesion of platelets to sites of vascular injury, however only the very large vWF multimers are haemostatically competent. Plasma vWF derives predominantly from the vascular endothelium and is of a smaller average multimer size to that found in the sub-endothelial matrix. The existence of plasma factors that control the size of vWF multimers and account for this difference has long been suspected. vWF cleaving protease (vWFCP), a metalloproteinase that regulates vWF multimer size by proteolytic cleavage, and thrombospondin-1 (TSP-1), a trimeric glycoprotein that uncouples multimers by reducing the disulfide-bonds which link individual subunits, are two such factors that have recently been identified. The large and ultra large vWF multimers play a central role in arterial thrombosis and agents that regulate their size hold promise as novel anti-thrombotic drugs.


πŸ“œ SIMILAR VOLUMES


Diagnosis of von Willebrand disease type
✍ Miller, Connie H.; Kelley, Leslie; Green, David πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 107 KB πŸ‘ 2 views

## Diagnosis of von Willebrand disease Type 2N (vWD 2N ), which mimics hemophilia A and its carrier state, is important for accurate genetic counseling and appropriate therapy. To make testing for the disorder more clinically applicable, we developed a simplified method for measurement of factor V

Role for platelet von willebrand factor
✍ Dr. R. Castillo; G. Escolar; J. Monteagudo; A. Ordinas; M. Garrido; M. Moia; A. πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 606 KB

Twelve infusions of plasma concentrates of von Willebrand factor (vWF) were given to four patients with severe (type 111) von Willebrand disease (vWD). Their prolonged bleeding times were either completely or partially corrected after five infusions and had not changed after the remaining seven. In